|
🐬
|
Mortality and causes of death in the WHO multinational study of vascular disease in diabetes
N. Morrish,
S.-L. Wang,
L. Stevens,
J. Fuller,
H. Keen,
A. T. N. Group
|
10 |
2001 |
10
🐬
|
|
🦁
|
CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall Study
J. Fuller,
M. Shipley,
G. Rose,
R. Jarrett,
H. Keen
|
9 |
1980 |
9
🦁
|
|
🐢
|
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
8 auth.
N. Chaturvedi,
A. Sjølie,
J. Stephenson,
H. Abrahamian,
M. Keipes,
Allesandro Castellarin,
...
Ž. Rogulja-Pepeonik,
J. Fuller
|
9 |
1998 |
9
🐢
|
|
🐢
|
Vascular risk factors and diabetic neuropathy.
8 auth.
S. Tesfaye,
N. Chaturvedi,
S. Eaton,
J. Ward,
C. Manes,
C. Ionescu-Tîrgoviste,
...
D. Witte,
J. Fuller
|
9 |
2005 |
9
🐢
|
|
🐜
|
Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.
10 auth.
Neese Jw,
Duncan P Bayse,
Robinson M,
Cooper T,
Stewart C,
J. Fuller,
...
M. Shipley,
G. Rose,
J. Jarrett,
H. Keen
|
9 |
1983 |
9
🐜
|
|
🐜
|
Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study
10 auth.
S. Tesfaye,
L. Stevens,
J. Stephenson,
J. Fuller,
M. Plater,
C. Ionescu-Tîrgoviste,
...
A. Nuber,
G. Pozza,
J. Ward,
T. S. Group
|
9 |
1996 |
9
🐜
|
|
🐢
|
ORAL HYPOGLYCÆMICS IN DIABETES MELLITUS
H. Keen,
R. Jarrett,
J. Fuller
|
8 |
1975 |
8
🐢
|
|
🐜
|
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
99 auth.
J. Armitage,
C. Baigent,
E. Barnes,
D. Betteridge,
L. Blackwell,
M. Blazing,
L. Bowman,
E. Braunwald,
R. Byington,
C. Cannon,
M. Clearfield,
H. Colhoun,
R. Collins,
B. Dahlöf,
Kelly Davies,
...
Barry J. Davis,
J. D. de Lemos,
J. Downs,
P. Durrington,
J. Emberson,
B. Fellström,
M. Flather,
I. Ford,
M. Franzosi,
J. Fulcher,
J. Fuller,
C. Furberg,
David Gordon,
S. Goto,
A. Gotto,
H. Halls,
C. Harper,
C. Hawkins,
W. Herrington,
G. Hitman,
H. Holdaas,
L. Holland,
A. Jardine,
J. Jukema,
J. Kastelein,
S. Kean,
A. Keech,
A. Kirby,
J. Kjekshus,
Genell Knatterud (deceased),
Robert H Knopp (deceased),
W. Koenig,
M. Koren,
V. Krane,
M. Landray,
J. Larosa,
E. Lonn,
P. Macfarlane,
S. MacMahon,
A. Maggioni,
R. Marchioli,
I. Marschner,
B. Mihaylova,
L. Moye,
S. Murphy,
H. Nakamura,
A. Neil,
C. Newman,
R. O'Connell,
C. Packard,
S. Parish,
T. Pedersen,
R. Peto,
M. Pfeffer,
N. Poulter,
D. Preiss,
C. Reith,
P. Ridker,
M. Robertson,
F. Sacks,
N. Sattar,
R. Schmieder,
P. Serruys,
P. Sever,
J. Shaw,
C. Shear,
J. Simes,
P. Sleight,
E. Spata,
L. Tavazzi,
J. Tobert,
G. Tognoni,
A. Tonkin,
S. Trompet,
J. Varigos,
C. Wanner,
H. Wedel,
H. White,
J. Wikstrand,
L. Wilhelmsen,
K. Wilson,
R. Young,
S. Yusuf,
F. Zannad
|
8 |
2019 |
8
🐜
|
|
🐜
|
Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.
18 auth.
T. Hoerger,
A. Bethke,
A. Richter,
Stephen W. Sorensen,
M. Engelgau,
T. Thompson,
K. Narayan,
D. Williamson,
E. Gregg,
Ping Zhang,
...
R. Eastman,
J. Fuller,
C. Gibbons,
S. Haffner,
W. Herman,
B. Howard,
R. Ratner,
T. Orchard
|
8 |
2002 |
8
🐜
|
|
🐜
|
The Role of Circulating Glucose and Triglyceride Concentrations and Their Interactions with Other “Risk Factors” as Determinants of Arterial Disease in Nine Diabetic Population Samples from the WHO Multinational Study
17 auth.
K. M. West,
M. Ahuja,
P. Bennett,
A. Czyżyk,
O. M. De Acosta,
J. Fuller,
B. Grab,
V. Grabauskas,
R. Jarrett,
K. Kosaka,
...
H. Keen,
A. Krolewski,
E. Miki,
V. Schliack,
A. Teuscher,
P. Watkins,
J. Stober
|
8 |
1983 |
8
🐜
|
|
🐜
|
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
8 auth.
N. Chaturvedi,
M. Porta,
R. Klein,
T. Orchard,
J. Fuller,
H. Parving,
...
R. Bilous,
A. Sjølie
|
8 |
2008 |
8
🐜
|
|
🐜
|
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial
8 auth.
A. Sjølie,
R. Klein,
M. Porta,
T. Orchard,
J. Fuller,
H. Parving,
...
R. Bilous,
N. Chaturvedi
|
8 |
2008 |
8
🐜
|
|
🐬
|
High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database.
S. Soedamah-Muthu,
J. Fuller,
H. Mulnier,
V. Raleigh,
R. Lawrenson,
H. Colhoun
|
8 |
2006 |
8
🐬
|
